Latest News
January 1, Pfizer working on COVID-19 pill
Pfizer is working on a pill to combat COVID-19.
The company announced that its first participant entered the second trial phase of the three-phase study of its oral antiviral. The pill is intended to mitigate symptoms and hospitalizations.
The treatment is administered in 12-hour increments for five days to people who are symptomatic but not hospitalized. The trial will consist of 1,140 participants who will either receive the pill or a placebo.
If successful, Pfizer’s oral antiviral could help alleviate the strains on health care systems, as the treatment could help reduce the number of hospitalizations.
Source:
Could There Be a Daily COVID Pill? What We Know About Pfizer Drug Trial
-
Entertainment3 years agoWhoopi Goldberg’s “Wildly Inappropriate” Commentary Forces “The View” into Unscheduled Commercial Break
-
Entertainment3 years ago‘He’s A Pr*ck And F*cking Hates Republicans’: Megyn Kelly Goes Off on Don Lemon
-
Featured3 years agoUS Advises Citizens to Leave This Country ASAP
-
Featured3 years agoBenghazi Hero: Hillary Clinton is “One of the Most Disgusting Humans on Earth”
-
Latest News3 years agoNude Woman Wields Spiked Club in Daylight Venice Beach Brawl
-
Featured3 years agoFox News Calls Security on Donald Trump Jr. at GOP Debate [Video]
-
Entertainment3 years agoComedy Mourns Legend Richard Lewis: A Heartfelt Farewell
-
Latest News3 years agoSupreme Court Gift: Trump’s Trial Delayed, Election Interference Allegations Linger